Ranitidine Zantac Cancer Will Make Headlines in 2021

More and more people may come forward when the government's investigation of Sanofi concludes

Monday, January 4, 2021 - The year 2020 brought us many developments that have affected consumer health like the Covid 19 pandemic and the rush to develop a vaccine to combat the Coronavirus. While people have had to deal with life and business disruptions brought on by government lockdowns intended to fight the virus' spread, the FDA recall of Zantac, the world's leading heartburn and acid reflux medication may have been even more disconcerting to people. Over 15 million Americans per year reached for the best-selling ant-acid medicine after having overeaten, eaten spicy foods, smoked, or drank caffeine or alcohol, among other reasons for feeling heartburn discomfort. Zantac and other heartburn medicine users were shocked last year when they tried to buy the over-the-counter medicine and found store shelves empty and were forced to suffer heartburn pain and misery. The FDA steered Zantac users to replace the recalled medicine with alternatives including Prilosec (omeprazole) Nexium (esomeprazole) Prevacid (lansoprazole), according to Drug Watch.com. All have tested negative for high levels of NDMA.

Sanofi, the maker of Zantac, voluntarily withdrew Zantac from the market early in 2020 when allegations were made to the FDA that the drug could contain elevated levels of NDMA, a known carcinogen. According to Organic Process R&D, " The US Food and Drug Administration recalled ranitidine, a common heartburn medication, due to unacceptable levels of the known carcinogen N-nitrosodimethylamine. Samples were found to contain up to 9 times the recommended safe level in a single 300 mg ranitidine dose." The FDA followed Sanofi's lead, taking it one step further in banning all types of ranitidine. It is suspected that NDMA contamination could have come from abnormally high drug storage temperatures, the drug's interaction with stomach nitrates, or contamination at the source in China where it is manufactured. It has come out recently that the most probable source of NDMA contamination is that ranitidine is inherently unstable.

This year, one of the largest mass tort lawsuits promises to be brought by users of the popular anti-heartburn and acid reflux medicine Zantac. People with stomach, bladder, or esophageal cancer, or many other types, have hired Zantac Cancer Lawyers to help them sort through the facts and file a claim against the drug's manufacturer. Legal minds think that tens of thousands of Zantac Cancer sufferers may come forward this year to press their case against Sanofi for failing to warn them of the dangers of using Zantac. Plaintiffs may be bolstered once the current federal investigation of Sanofi for lying about what they knew regarding Zantac and NDMA is made public.

It is unknown when or if Zantac and other ranitidine heartburn medicines will return to the market and users have been advised to avoid them until the FDA concluded its NDMA contamination study. Canada is allowing ranitidine to be sold but requires manufacturers to test the drug for NDMA levels frequently. Companies can be expected to remove the product from the market should the carcinogen be present above the acceptable level of 96 ng per tablet. There is no indication currently that the US will follow suit.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.